Torfinn Aanes

  • Citations Per Year
Learn More
OBJECTIVE Costly biologic therapies have improved function and quality of life for patients suffering from rheumatic and inflammatory bowel diseases. In this survey, we aimed to document and analyze the costs. METHODS In 2008, the total costs of tumor necrosis factor alpha inhibitors and other biologic agents in Norway were registered prospectively. In(More)
  • 1